Screening for C 9 ORF 72 repeat expansion in FTLD

Raffaele Ferrari1,2, Kin Mok2, Jorge H. Moreno1, Stephanie Cosentino3, Jill Goldman3, Pietro Pietrini6, Richard Mayeux3, Michael C. Tierney5, Dimitrios Kapogiannis5,7, Gregory A. Jicha9, Jill R Murrell8, Bernardino Ghetti8, Eric M Wassermann5, Jordan Grafman4,5, John Hardy2, Edward D. Huey3,5, and Parastoo Momeni1,* 1Laboratory of Neurogenetics, Department of Internal Medicine, Texas Tech University Health Sciences Center, 3601 4th St. STOP 9410, Lubbock, Texas ,79430, USA 2Institute of Neurology, University College London, Queen Sq., London WC1N 3BG, United Kingdom 3Taub Institute for Research on Alzheimer’s Disease and the Aging Brain The Gertrude H. Sergievsky Center Columbia University 630 West 168th Street P&S Box 16 New York, NY 10032 4Kessler Foundation Research Center 1199 Pleasant Valley Way West Orange, New Jersey 07052 5Cognitive Neuroscience Section, NINDS/NIH, Bethesda, MD 6Laboratory of Clinical Biochemistry and Molecular Biology, University of Pisa Medical School, Pisa (Italy) 7Clinical Research Branch, National Institute on Aging/National, Institutes of Health (NIA/NIH) 8Indiana Alzheimer Disease Center, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis 9Sanders-Brown Center on Aging, University of Kentucky Alzheimer’s Disease Center, 800 South Limestone Street, Lexington, KY 40536-0230